Labradoodle & Goldendoodle Forum
As many of you may or may not know, there is a nationwide shortage of Immiticide the arsenic based drug and the ONLY drug approved by the FDA for treatment of heartworm in dogs.
Merial, the ONLY pharmaceutical company that manufactures Immiticide has, ( for profit margin reasons,) ceased production of the drug! They have NO immediate plans to continue production in the near future!
The entire veterinary industry as well as the entire animal welfare community are up in arms about this situation and I assure you the situation is desperate!
BOTTOM LINE: NO ONE HAS ANY IMMITICIDE ON HAND. Nationwide resources have been DEPLETED.
That leaves us with absolutely no way to treat heartworm positive dogs other than via the 1 year, slow-kill method with the strict administering of monthly Heart Guard preventive.
FYI-Heart Guard is the ONLY tested and approved method for the slow-killing of Heartworms in positive dogs.
Interceptor and other preventatives that use milbemycin oxime are NOT APPROVED for HW positive dogs as they can cause a HW positive dog to embolize as the adult worms die off .......That means certain death.
Already, many shelters across the country that HW test dogs at intake, are immediately euthanizing any and all who test positive.
The situation is grave ......And it is only going to get worse.
DRC averages between 15-25 HW cases per year and like many animal welfare organizations across the nation, we are shocked, outraged, appalled and quite frankly we are frightened by the potential impact this will have on our ability to treat HW positive doodles in our rescue program.
Immiticide Supplies Run Dry
August 9, 2011
By: Jennifer Fiala
For The VIN News Service
"This is Zappo," he said from the Peachtree Hills Veterinary clinic. In response to raised eyebrows, he added, "Atlanta Lab Rescue gets creative with their names."
Zappo nudges the camera and thumps his tail. Like most labs, he's all heart. But his heart is a little too big. Dr. Jones points to cloudy white spots on an X-ray. Zappo is infected with heartworms.
(Click here to read more about Heartworm from the American Heartworm Society.)
"Of all of the diseases we see, this one is the most preventable," Dr. Jones said. "That's why it's so frustrating."
Mosquitoes carry the parasites easily in warm areas like Georgia. It can be fatal to your dog.
Dr. Jones will use his last two boxes of Immiticide to treat Zappo and another rescue lab. The next heartworm infected dog that comes into his Peachtree Hills office will not get the medicine he needs.
"This is going to be hard for all of us," Jones said. "For us, the frustration [is] that we can't help these dogs."
Merial, a pharmaceutical company owned by Sanofi, is the only FDA-approved company to make Immiticide, the treatment for heartworm-infected dogs. Earlier this month, they sent letters to vets nationwide saying a technical issue caused a supply disruption.
They're out.
In a letter to 11Alive News, a Merial spokesman wrote: "As a result of this new supply interruption, we have depleted our inventory of IMMITICIDE and anticipate that the outage will last from several weeks to months... Merial and the IMMITICIDE manufacturer fully understand the critical need for the product and regret this outage. We are working together to return to full supply as quickly as possible."
At the Atlanta Humane Society, Dr. Gloria Dorsey is forced to make difficult choices.
"It's like triage." She said. "We have to select very carefully which individuals might be better candidates for treatment. Unfortunately, the rest go on the back burner while we wait for more medicine to be produced."
Lilly and Rosie were rescued from a hoarding house in Alabama. Winn Dixie was surrendered. They are lucky: they're being treated with Immiticide. But the clinic is on a limited supply, and no one knows when production will get back online.
There's a simple way to protect your dog: preventative medicine. Monthly heartworm preventative medicine costs less than $10 a month. But, a new map released by the American Heartworm Society shows the number of cases has gone up in between 2007 and 2010.
The spread is due, in part, to pet-owners cutting corners, saving money, not protecting their dogs. Now, with the only cure in short supply, vets are forced to put infected dogs in a "holding pattern." They keep them as inactive as possible since higher heart rates spread heartworms faster. Anti-inflammatories treat the symptoms. Vets like Dr. Jones say they're hoping to keep them alive and undamaged for weeks or months until production resumes.
"It's very concerning to all of us in the veterinary community," Jones said.
The Atlanta Journal-Constitution
A nationwide shortage of medication used to kill heartworms in dogs is "not catastrophic," say animal health professionals.
Duluth-based Merial, distributor of Immiticide, the only FDA-approved drug available to treat adult heartworms in dogs, sent letters earlier this month to veterinarians informing them of the depletion of inventory. The news was not unexpected; the company warned of production problems as far back as December 2009.
Merial spokesman Steve Dickinson said "technical issues" have halted the production of Immiticide by a third-party supplier. The company is "trying as hard as [it] can" to resume production or find an alternative supplier, he said.
Dickinson said one of the problems is that the active ingredient in Immiticide, melarsomine, is difficult to manufacture. Melarsomine, a derivative of arsenic, is effective at killing adult heartworms -- a parasitic roundworm transmitted by mosquitoes -- that infest animal arteries and can cause death.
Currently, Merial has no Immiticide to sell to veterinarians, said Dickinson. He did not know when production would resume, saying only that the problem could last several weeks or months.
Those in the animal health care field say that while the lack of Immiticide is a problem, it's no cause for panic.
Scott Zimmerman, a manager at Dearborn Animal Hospital in Decatur, said pets on routine heartworm preventative medication are at a very low risk of contracting heartworm disease.
But, dogs with adult heartworms can't "currently be treated with the best medicine," said Zimmerman.
The lack of Immiticide "is not a death sentence," said Becky Cross, founder of Atlanta Lab Rescue.
Cross said roughly half of the 350 animals her group find homes for each year must be treated for heartworms, which can cost upwards of $800.
"A lot of shelters that test for heartworms will just put animals to sleep," said Cross, who estimated more than half of the $120,000 Atlanta Lab Rescue spent on vet bills in 2010 was for heartworm treatments. "Lots of rescue groups won’t take heartworm-positive dogs"
Atlanta Lab Rescue will begin using a cheaper but less effective "slow kill" method to treat the infected animals it has up for adoption, Cross said.
The slow kill method, which only kills worm larvae, involves giving a dog monthly heartworm preventative medication -- which costs about $15 a month -- and waiting a year or more for the adult heartworms to die.
Dr. Duffy Jones, a veterinarian and owner of Peachtree Hills Animal Hospital, who works with Atlanta Lab Rescue, said the slow kill method is "not ideal" for two reasons -- it takes a year or more for the adult heartworms to die, which can lead to additional scarring of the dog's heart and lungs; and the animal cannot exercise during that time.
"The Immiticide being gone is problematic but not catastrophic,” said Jones, who stressed the need for routine preventative medication.
Dr. Susan B. Krebsbach, a veterinarian with the Humane Society Veterinary Medical Association, said the extended treatment schedule is likely to slow the adoption rate of shelter dogs.
"Dogs that test positive are going to be positive for a lot longer," she said.
Krebsbach said Merial's production problems have made vets more aware of less expensive drugs, such as doxycyline, an antibiotic that has proven to reduce the viability of heartworm larvae, which should reduce transmission rates. The antibiotic, combined with a heartworm preventative, also shortens the lifespan of the adult heartworms and lessens problems associated with worm death, she said.
Merial, the animal health division of Sanofi, employs 5,600 globally. About 600 work at the company's Duluth headquarters.
Tags:
© 2025 Created by Adina P. Powered by